News | November 01, 2024
AbbVie to acquire Aliada Therapeutics
Strengthening focus in Alzheimer's disease and neuroscience pipeline
Strengthening focus in Alzheimer's disease and neuroscience pipeline
The INTerpath-009 clinical trial demonstrates continued expansion of the INTerpath clinical program
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
VYALEV is the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor fluctuations in advanced Parkinson's disease
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
Buckley served as Chairman and Chief Executive Officer at Vanguard from 2018 until his retirement in 2024
The market size of Aspart in India is currently estimated over Rs. 260 crore with only 2 players
Lyka has received the CDSCO approval for manufacturing and marketing of Pregabalin Gel 8% w/w
Declan brings over 25 years of expertise in the pharmaceutical and biotech sectors
Subscribe To Our Newsletter & Stay Updated
